Follow-up tests play a crucial role in minimizing the impact of Type II errors. If a screening test indicates a negative result but there are symptoms or risk factors present, additional tests such as biopsies, advanced imaging, or blood tests may be recommended. These follow-up tests can either confirm the initial result or identify the presence of cancer that was missed in the initial screening.
